CTOR
CITIUS ONCOLOGY, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$1.14
+11.76%Aug 14, 2026, 00:00 UTC
Citius Oncology, Inc. reported its Q3 2026 financial results, with revenue of $1.5 million and a net loss of $8.9 million.
NASDAQ · Healthcare · Drug Manufacturers - General · US
Aug 14, 2026, 00:00 UTC